SPECTRANETICS CORP·4

Jan 24, 4:40 PM ET

SPECTRANETICS CORP 4

4 · SPECTRANETICS CORP · Filed Jan 24, 2008

Insider Transaction Report

Form 4
Period: 2008-01-22
Rasmussen Thomas M
VP of Clinical Affairs
Transactions
  • Award

    SPNC Stock Options

    2008-01-22+20,00020,000 total
    Exercise: $13.31Exp: 2018-01-22SPNC Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]Options are on a 4 year 100% vesting schedule; fully vested on 1/22/2012. Options expire at the end of 10 years, or on 1/22/2018.
  • [F2]Price of derivitive security is reported in Table II, Column 2.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION